Comprehensive molecular cytogenetic characterization of cervical cancer cell lines

被引:86
作者
Harris, CP
Lu, XY
Narayan, G
Singh, B
Murty, VVVS
Rao, PH
机构
[1] Baylor Coll Med, Lab Mol Cytogenet, Texas Childrens Canc Ctr, Houston, TX 77030 USA
[2] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA
[4] Mem Sloan Kettering Canc Ctr, Lab Epithelial Canc Biol, New York, NY 10021 USA
关键词
D O I
10.1002/gcc.10158
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We applied a combination of molecular cytogenetic methods, including comparative genomic hybridization (CGH), spectral karyotyping (SKY), and fluorescence in situ hybridization (FISH), to characterize the genetic aberrations in eight widely used cervical cancer (CC) cell lines. CGH identified the most frequent chromosomal losses including 2q, 3p, 4q, 6q, 8p, 9p, lop, 13q, and 18q; gains including 3q, Sp, 5q, 8q, 9q, 11q, 14q, 16q, 17q, and 20q; and high-level chromosomal amplification at 3q21, 7p11, 8q23-q24, 10q21, 11q13, 16q23-q24, 20q11q, and 20q13. Several recurrent structural chromosomal rearrangements, including der(5)t(5;8)(p13;q23) and i(5)(p10); deletions affecting chromosome bands 5p11, 5q11, and 11q23; and breakpoint clusters at 2q31, 3p10, 3q25, 5p13, 5q11, 7q11.2, 7q22, 8p11.2, 8q11.2, 10p11.2, 11p11.2, 14q10, 15q10, 18q21, and 22q11.2 were identified by SKY. We detected integration of HPV16 sequences by FISH on the derivative chromosomes involving bands 18p10 and 18p11 in cell line C-41, 2p16, 5q21, 5q23, 6q, 8q24, 10, 11p11, 15q, and 18p11 in Ca Ski, and normal chromosome 17 at 17p13 in ME-180. FISH analysis was also used further to determine the copy number changes of PIKA3CA and MYC. This comprehensive cytogenetic characterization of eight CC cell lines enhances their utility in experimental studies aimed at gene discovery and functional analysis. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:233 / 241
页数:9
相关论文
共 28 条
  • [21] Multicolor spectral karyotyping of human chromosomes
    Schrock, E
    duManoir, S
    Veldman, T
    Schoell, B
    Wienberg, J
    FergusonSmith, MA
    Ning, Y
    Ledbetter, DH
    BarAm, I
    Soenksen, D
    Garini, Y
    Ried, T
    [J]. SCIENCE, 1996, 273 (5274) : 494 - 497
  • [22] PIK3CA is implicated as an oncogene in ovarian cancer
    Shayesteh, L
    Lu, YL
    Kuo, WL
    Baldocchi, R
    Godfrey, T
    Collins, C
    Pinkel, D
    Powell, B
    Mills, GB
    Gray, JW
    [J]. NATURE GENETICS, 1999, 21 (01) : 99 - 102
  • [23] p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas
    Singh, B
    Reddy, PG
    Goberdhan, A
    Walsh, C
    Dao, S
    Ngai, I
    Chou, TC
    O-charoenrat, P
    Levine, AJ
    Rao, PH
    Stoffel, A
    [J]. GENES & DEVELOPMENT, 2002, 16 (08) : 984 - 993
  • [24] Singh B, 2001, CANCER RES, V61, P4506
  • [25] Karyotyping human chromosomes by combinatorial multi-fluor FISH
    Speicher, MR
    Ballard, SG
    Ward, DC
    [J]. NATURE GENETICS, 1996, 12 (04) : 368 - 375
  • [26] Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression
    Umayahara, K
    Numa, F
    Suehiro, Y
    Sakata, A
    Nawata, S
    Ogata, H
    Suminami, Y
    Sakamoto, M
    Sasaki, K
    Kato, H
    [J]. GENES CHROMOSOMES & CANCER, 2002, 33 (01) : 98 - 102
  • [27] Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas
    Zhang, AJ
    Zheng, CY
    Hou, M
    Lindvall, C
    Wallin, KL
    Ångström, T
    Yang, XY
    Hellström, AC
    Blennow, E
    Björkholm, M
    Zetterberg, A
    Gruber, A
    Xu, DW
    [J]. GENES CHROMOSOMES & CANCER, 2002, 34 (03) : 269 - 275
  • [28] zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690